N/A
Manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE
23 FDA adverse event reports analyzed
Last updated: 2026-04-15
CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE. The most commonly reported adverse reactions for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR include DRUG ABUSE, CARDIAC ARREST, RESPIRATORY ARREST, ASTHENIA, BALANCE DISORDER. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR.
Out of 9 classified reports for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.